SWShang Wan

Shang Wan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shang Wan has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Song

    Department of Radiology, West China Hospital, Sichuan University, Chengdu, China

    2 shared publications
  • Cai-Wei Yang

    Department of Radiology, West China Second University Hospital of Sichuan University, Chengdu, China

    1 shared publication
  • Feng Che

    1 shared publication
  • Fubi Hu

    Department of Radiology The First Affiliated Hospital of Chengdu Medical College Chengdu China

    1 shared publication
  • Guofeng Liu

    From the Department of Gastroenterology and Hepatology, Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, Chengdu, China, scu.edu.cn

    1 shared publication
  • Ju Huang

    Department of Gastroenterology and Hepatology, Laboratory of Gastrointestinal Cancer and Liver Disease, West China Hospital Sichuan University Chengdu China

    1 shared publication

Latest Publications

  • Completely Occlusive Portal Vein Thrombosis as a Predictor of Mortality in Acute Variceal Bleeding

    by Xiaoze Wang, Ju Huang, Guofeng Liu, Tong Xiang, Yazhou He, Shang Wan, Ziqi Chen, Li Yang, Xuefeng Luo

    Background: Risk stratification plays a critical role in acute variceal bleeding (AVB) management, while portal vein thrombosis (PVT) has uncertain prognostic significance in AVB. Aim: This study aimed to investigate the impact of PVT on the prognosis of patients with cirrhosis and AVB, with a particular focus on the influence of PVT severity stratification. Methods: A retrospective analysis was conducted on 1389 cirrhotic patients with PVT ( n = 292, 21.1%) and without PVT ( n = 1096, 78.9%) admitted between 2016 and 2022 due to AVB. Patients were stratified based on PVT presence and severity according to the AASLD criteria. Propensity score matching was applied to balance baseline characteristics. The primary endpoint was 6‐week mortality. Results: The overall 6‐week mortality was 8.6%. Patients with PVT had a similar risk of mortality compared with those without PVT (10.14% vs. 8.10%; HR 1.26, 95% CI 0.81–1.96, p = 0.306). However, complete occlusive PVT was associated with significantly higher 6‐week mortality compared to non‐PVT patients (35.3% vs. 8.1%; HR 5.61, 95% CI 2.61–11.90, p < 0.001). Transjugular intrahepatic portosystemic shunt (TIPS) could reduce the risk in these patients (0% vs. 44.4%; HR 0.22, 95% CI 0.05–0.97, p = 0.046). Conclusions: Patients with completely occlusive PVT had a higher risk of 6‐week mortality after AVB. These findings highlight the importance of incorporating PVT severity into AVB risk stratification and support considering TIPS in high‐risk patients, although the benefit of preemptive TIPS needs further investigation.


  • Deep Learning‐Enhanced CTA for Noninvasive Prediction of First Variceal Haemorrhage in Cirrhosis: A Multi‐Centre Study

    by Shang Wan, Yuan Gao, Tengfei Li, Xiaohe Tian, Minghui Liu, Yi Wei, Feng Che, Wei Ren, Ming Liu, Fubi Hu, et al.

    Background and Aims: The first variceal haemorrhage (FVH) is a life‐threatening complication of liver cirrhosis that requires timely intervention; however, noninvasive tools for accurately predicting FVH remain limited. This study aimed to develop noninvasive, deep learning‐enhanced computed tomographic angiography (CTA) models for early and accurate FVH prediction. Methods: This multi‐centre retrospective study included 184 cirrhotic patients (FVH: n = 107, non‐FVH: n = 77) enrolled from December 2014 to May 2022. Patients were randomly divided (7:3) into training and validation cohorts. CTA and clinical data were collected and analysed. A novel Vision‐Transformer (ViT) network, combined with reinforcement learning (RL), was applied to CTA images to predict FVH and was compared with convolutional neural networks (CNNs). Models were evaluated using the area under the receiver operating characteristic curve (AUC) and decision curve analysis (DCA), and feature importance was determined from model coefficients and gradients. Results: The ViT + RL* model demonstrated superior diagnostic performance, achieving an AUC of 0.985 (95% CI, 0.955–1.0) in the validation cohort and 0.956 (95% CI, 0.919–0.988) in the training cohort, outperforming traditional CNNs. DCA and the area under the curve confirmed the enhanced clinical utility of the ViT + RL* model compared to CNNs; the ViT + RL* model highlighted critical regions in the liver, spleen, oesophageal lumen, and abdominal vessels. Meanwhile, clinical data identified creatinine and prothrombin time as potential predictive factors, with moderate predictive performance. Conclusions: The novel deep learning‐enhanced CTA models offer a robust, non‐invasive method for predicting FVH, with the ViT + RL* model demonstrating excellent efficacy; thus providing a valuable tool for early risk stratification in cirrhotic patients.


  • Open Access

    Current and Potential Applications of Artificial Intelligence in Gastrointestinal Stromal Tumor Imaging

    by Cai-Wei Yang, Xi-Jiao Liu, Si-Yun Liu, Shang Wan, Zheng Ye, Bin Song

    The most common mesenchymal tumors are gastrointestinal stromal tumors (GISTs), which have malignant potential and can occur anywhere along the gastrointestinal system. Imaging methods are important and indispensable of GISTs in diagnosis, risk staging, therapy, and follow-up. The recommended imaging method for staging and follow-up is computed tomography (CT) according to current guidelines. Artificial intelligence (AI) applies and elaborates theses, procedures, modes, and utilization systems for simulating, enlarging, and stretching the intellectual capacity of humans. Recently, researchers have done a few studies to explore AI applications in GIST imaging. This article reviews the present AI studies in GISTs imaging, including preoperative diagnosis, risk stratification and prediction of prognosis, gene mutation, and targeted therapy response.